1.Simplified Assessment of Lesion Water Uptake for Identification of Patients within 4.5 Hours of StrokeOnset: An Analysis of the MissPerfeCT Study
Peter B. SPORNS ; Marco HÖHNE ; Lennart MEYER ; Christos KROGIAS ; Volker PUETZ ; Kolja M. THIERFELDER ; Marco DUERING ; Daniel KAISER ; Sönke LANGNER ; Alex BREHM ; Lukas T. ROTKOPF ; Wolfgang G. KUNZ ; Jens FIEHLER ; Walter HEINDEL ; Peter SCHRAMM ; Heinz WIENDL ; Heike MINNERUP ; Marios Nikos PSYCHOGIOS ; André KEMMLING ; Jens MINNERUP
Journal of Stroke 2022;24(3):390-395
and Purpose Many patients with stroke cannot receive intravenous thrombolysis because the time of symptom onset is unknown. We tested whether a simple method of computed tomography (CT)-based quantification of water uptake in the ischemic tissue can identify patients with stroke onset within 4.5 hours. Methods This retrospective analysis of the MissPerfeCT study (August 2009 to November 2017) includes consecutive patients with known onset of symptoms from seven tertiary stroke centers. We developed a simplified algorithm based on region of interest (ROI) measurements to quantify water uptake of the ischemic lesion and thereby quantify time of symptom onset within and beyond 4.5 hours. Perfusion CT was used to identify ischemic brain tissue, and its density was measured in non-contrast CT and related to the density of the corresponding area of the contralateral hemisphere to quantify lesion water uptake. Results Of 263 patients, 204 (77.6%) had CT within 4.5 hours. Water uptake was significantly lower in patients with stroke onset within (6.7%; 95% confidence interval [CI], 6.0% to 7.4%) compared to beyond 4.5 hours (12.7%; 95% CI, 10.7% to 14.7%). The area under the curve for distinguishing these patient groups according to percentage water uptake was 0.744 with an optimal cut-off value of 9.5%. According to this cut-off the positive predictive value was 88.8%, sensitivity was 73.5%, specificity 67.8%, negative predictive value was 42.6%. Conclusions Ischemic stroke patients with unknown time of symptom onset can be identified as being within a timeframe of 4.5 hours using a ROI-based method to assess water uptake on admission non-contrast head CT.
2.Safety and Angiographic Efficacy of Intra-Arterial Fibrinolytics as Adjunct to Mechanical Thrombectomy: Results from the INFINITY Registry
Johannes KAESMACHER ; Nuran ABDULLAYEV ; Basel MAAMARI ; Tomas DOBROCKY ; Jan VYNCKIER ; Eike I. PIECHOWIAK ; Raoul POP ; Daniel BEHME ; Peter B. SPORNS ; Hanna STYCZEN ; Pekka VIRTANEN ; Lukas MEYER ; Thomas R. MEINEL ; Daniel CANTRÉ ; Christoph KABBASCH ; Volker MAUS ; Johanna PEKKOLA ; Sebastian FISCHER ; Anca HASIU ; Alexander SCHWARZ ; Moritz WILDGRUBER ; David J. SEIFFGE ; Sönke LANGNER ; Nicolas MARTINEZ-MAJANDER ; Alexander RADBRUCH ; Marc SCHLAMANN ; Dan MIHOC ; Rémy BEAUJEUX ; Daniel STRBIAN ; Jens FIEHLER ; Pasquale MORDASINI ; Jan GRALLA ; Urs FISCHER
Journal of Stroke 2021;23(1):91-102
Background:
and Purpose Data on safety and efficacy of intra-arterial (IA) fibrinolytics as adjunct to mechanical thrombectomy (MT) are sparse.
Methods:
INtra-arterial FIbriNolytics In ThrombectomY (INFINITY) is a retrospective multi-center observational registry of consecutive patients with anterior circulation large-vessel occlusion ischemic stroke treated with MT and adjunctive administration of IA fibrinolytics (alteplase [tissue plasminogen activator, tPA] or urokinase [UK]) at 10 European centers. Primary outcome was the occurrence of symptomatic intracranial hemorrhage (sICH) according to the European Cooperative Acute Stroke Study II definition. Secondary outcomes were mortality and modified Rankin Scale (mRS) scores at 3 months.
Results:
Of 5,612 patients screened, 311 (median age, 74 years; 44.1% female) received additional IA after or during MT (194 MT+IA tPA, 117 MT+IA UK). IA fibrinolytics were mostly administered for rescue of thrombolysis in cerebral infarction (TICI) 0-2b after MT (80.4%, 250/311). sICH occurred in 27 of 308 patients (8.8%), with an increased risk in patients with initial TICI0/1 (adjusted odds ratio [aOR], 2.3; 95% confidence interval [CI], 1.1 to 5.0 per TICI grade decrease) or in those with intracranial internal carotid artery occlusions (aOR, 3.7; 95% CI, 1.2 to 12.5). In patients with attempted rescue of TICI0-2b and available angiographic follow-up, 116 of 228 patients (50.9%) showed any angiographic reperfusion improvement after IA fibrinolytics, which was associated with mRS ≤2 (aOR, 3.1; 95% CI, 1.4 to 6.9).
Conclusions
Administration of IA fibrinolytics as adjunct to MT is performed rarely, but can improve reperfusion, which is associated with better outcomes. Despite a selection bias, an increased risk of sICH seems possible, which underlines the importance of careful patient selection.